Important Safety Information About PRISTIQ

Suicidality and Antidepressant Drugs Antidepressants increased the risk of suicidal thinking and behavior in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy or when the dose is changed should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior such as becoming agitated, irritable, hostile, aggressive, impulsive, or restless. Should these occur, report them to a doctor right away. PRISTIQ is not approved for use in children under 18.

See More Important Safety Information >

Doctor Discussion Guide

Bringing a list of things to discuss with your doctor can help focus your conversation in the time you have together. Simply answer the following 6 questions, and we’ll provide you with some suggestions.

QUESTION 1 OF 6

What’s your depression status?

QUESTION 2 OF 6

What’s your treatment status?

QUESTION 3 OF 6

What are your concerns about taking an antidepressant?

(Check all that apply)

QUESTION 4 OF 6

Which statement(s) best describe you?

(Check all that apply)

QUESTION 5 OF 6

How often do depression symptoms affect your interest in your favorite activities?

QUESTION 6 OF 6

What type of doctor treats your depression?

This is not intended to result in a diagnosis or a treatment recommendation. It's meant to help you have a more meaningful discussion with your doctor. No information about you will be collected or stored.

Important Safety Information About PRISTIQ

Suicidality and Antidepressant Drugs

Antidepressants increased the risk of suicidal thinking and behavior in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy or when the dose is changed should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior such as becoming agitated, irritable, hostile, aggressive, impulsive, or restless. Should these occur, report them to a doctor right away. PRISTIQ is not approved for use in children under 18.

Do not take PRISTIQ if you are allergic to desvenlafaxine, venlafaxine, or any of the ingredients in PRISTIQ. Do not take PRISTIQ if you currently take, or have taken within the last 14 days, any medicine known as an MAOI (including intravenous methylene blue or the antibiotic linezolid). Allow 7 days after stopping PRISTIQ before starting an MAOI. Taking an MAOI with PRISTIQ can cause serious or even life-threatening side effects.

Before taking PRISTIQ, tell your healthcare professional about all prescription and over-the-counter medications and supplements you take or plan to take including: those to treat migraines or psychiatric disorders (including other antidepressants) to avoid serotonin syndrome, a potentially life-threatening condition; aspirin, NSAID pain relievers, or blood thinners because they may increase the risk of bleeding.

PRISTIQ may cause or worsen some conditions, so tell your healthcare professional about all the medical conditions you have or had including:

High blood pressure, which should be controlled before starting PRISTIQ and monitored regularly
Heart problems, high cholesterol or triglyceride levels, a history of stroke, glaucoma or increased eye pressure, kidney or liver problems, or low sodium levels in your blood
Bleeding problems
Depression, suicidal thoughts or behavior
Mania, bipolar disorder, or seizures or convulsions
Nursing, pregnancy, or plans to become pregnant

Discontinuation symptoms may occur when stopping or reducing PRISTIQ, so talk to your healthcare professional before stopping or changing your dose.

Until you see how PRISTIQ affects you, be careful driving a car or operating machinery. Avoid drinking alcohol while taking PRISTIQ.

In clinical studies, most common side effects with PRISTIQ 50 mg were nausea, dizziness, sweating, constipation, and decreased appetite.

INDICATION

PRISTIQ^® (desvenlafaxine) is a prescription medication approved for the treatment of major depressive disorder in adults.

Please see full Prescribing Information, including boxed warning, and Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.

The product information provided in this site is intended for residents of the United States. The products discussed herein may have different product labeling in different countries.

Important Safety Information | Medication Guide for Patients | Prescribing Information |

Health Care Professionals \| Press Releases \| Unsubscribe \| Pfizer.com \|
Contact Us \| Privacy Policy \| Privacy Policy FAQs \| Terms of Use \| Site Map

PQP533710-01

The Science of Depression

Treating Depression

Healthy Living